Status:
RECRUITING
Optimizing Engagement in Services for First-Episode Psychosis
Lead Sponsor:
California State University, San Bernardino
Collaborating Sponsors:
University of Southern California
Olive View-UCLA Education & Research Institute
Conditions:
Engagement, Patient
First Episode Psychosis
Eligibility:
All Genders
15-35 years
Phase:
NA
Brief Summary
This study will compare a 12-session behavioral activation (BA) intervention modified for first-episode psychosis (FEP) to usual community mental health care (i.e., treatment-as-usual; TAU) delivered ...
Detailed Description
After an initial pre-screen, screening, and pre-intervention assessment, enrolled participants will be randomized to either BA or TAU. The study intervention phase will last up to 6 months, during whi...
Eligibility Criteria
Inclusion
- Self-identification as Latino
- Age 15 to 35
- Diagnostic \& Statistical Manual of Mental Disorders-5 diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, other specified schizophrenia spectrum, affective psychosis, and other psychotic disorder criteria
- Ability to speak English or Spanish
- Caregiver willing to consent to participate in the study and care
- Ability to provide fully informed consent
Exclusion
- Diagnosis of psychotic disorder due to another medical condition or substance/medication-induced psychotic disorder
- Presence of a serious medical condition
- 3≤ years after the onset
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT05310838
Start Date
March 1 2022
End Date
February 28 2026
Last Update
March 26 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
San Fernando Mental Health Center
Granada Hills, California, United States, 91344
2
Olive View - UCLA Medical Center
Sylmar, California, United States, 91342